Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8915 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8846 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8605 |
High Similarity |
NPD4749 |
Approved |
0.8582 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8582 |
High Similarity |
NPD1613 |
Approved |
0.8496 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8496 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8296 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.8168 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8148 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8047 |
Intermediate Similarity |
NPD6671 |
Approved |
0.8029 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8016 |
Intermediate Similarity |
NPD228 |
Approved |
0.8014 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8014 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7868 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7863 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7852 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7815 |
Intermediate Similarity |
NPD1934 |
Approved |
0.781 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7761 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7724 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7681 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7671 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD1653 |
Approved |
0.766 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.766 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.766 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.766 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7647 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7647 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7647 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7647 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.763 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7615 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7578 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7576 |
Intermediate Similarity |
NPD7340 |
Approved |
0.7574 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7564 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7548 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7517 |
Intermediate Similarity |
NPD1511 |
Approved |
0.75 |
Intermediate Similarity |
NPD7157 |
Approved |
0.75 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7483 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7481 |
Intermediate Similarity |
NPD1398 |
Phase 1 |
0.7468 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7464 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7455 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7455 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7453 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7442 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7442 |
Intermediate Similarity |
NPD3021 |
Approved |
0.744 |
Intermediate Similarity |
NPD846 |
Approved |
0.744 |
Intermediate Similarity |
NPD940 |
Approved |
0.7438 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7438 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7405 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7394 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7362 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7355 |
Intermediate Similarity |
NPD37 |
Approved |
0.7347 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7325 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7325 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7324 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7315 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7303 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7301 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7297 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7287 |
Intermediate Similarity |
NPD290 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7261 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7261 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7256 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7241 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7241 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7237 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.723 |
Intermediate Similarity |
NPD5763 |
Approved |
0.723 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.723 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7226 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7205 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7205 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7197 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.719 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7179 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7178 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7162 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7134 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7117 |
Intermediate Similarity |
NPD27 |
Approved |
0.7117 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7115 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7115 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7114 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7103 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7095 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7087 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7086 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7083 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7083 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7083 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7083 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7083 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7083 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7066 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7063 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7055 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7055 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7039 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.703 |
Intermediate Similarity |
NPD8251 |
Approved |
0.703 |
Intermediate Similarity |
NPD8252 |
Approved |
0.703 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.7029 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7029 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7024 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7024 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7021 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7018 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7018 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7018 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7014 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7007 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD3051 |
Approved |
0.6993 |
Remote Similarity |
NPD6584 |
Phase 3 |
0.6988 |
Remote Similarity |
NPD8156 |
Discontinued |
0.6981 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD3748 |
Approved |
0.6975 |
Remote Similarity |
NPD5494 |
Approved |
0.6964 |
Remote Similarity |
NPD7240 |
Approved |
0.6962 |
Remote Similarity |
NPD6072 |
Discontinued |
0.6959 |
Remote Similarity |
NPD4097 |
Suspended |
0.6959 |
Remote Similarity |
NPD4663 |
Approved |
0.6959 |
Remote Similarity |
NPD6353 |
Approved |
0.6954 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6954 |
Remote Similarity |
NPD2424 |
Discontinued |
0.695 |
Remote Similarity |
NPD2232 |
Approved |
0.695 |
Remote Similarity |
NPD2233 |
Approved |
0.695 |
Remote Similarity |
NPD2230 |
Approved |
0.695 |
Remote Similarity |
NPD1608 |
Approved |
0.6948 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6941 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6939 |
Remote Similarity |
NPD1240 |
Approved |
0.6937 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6933 |
Remote Similarity |
NPD2161 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD2797 |
Approved |
0.6923 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD3144 |
Approved |
0.6918 |
Remote Similarity |
NPD5110 |
Phase 2 |
0.6918 |
Remote Similarity |
NPD5111 |
Phase 2 |
0.6918 |
Remote Similarity |
NPD5109 |
Approved |
0.6918 |
Remote Similarity |
NPD3145 |
Approved |
0.6913 |
Remote Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.6913 |
Remote Similarity |
NPD4536 |
Approved |
0.6913 |
Remote Similarity |
NPD4538 |
Approved |
0.6908 |
Remote Similarity |
NPD5177 |
Phase 3 |
0.6903 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6903 |
Remote Similarity |
NPD2532 |
Approved |
0.6903 |
Remote Similarity |
NPD2533 |
Approved |
0.6903 |
Remote Similarity |
NPD2534 |
Approved |
0.6899 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6892 |
Remote Similarity |
NPD447 |
Suspended |
0.689
|
Remote Similarity |
NPD3787 |
Discontinued |